Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Using advanced MRI to study Parkinson's disease

Official title: 7.0T Magnetic Resonance Imaging Study of Parkinson's Disease

Run by Chinese PLA General Hospital · NCT06449404 · Data updated 2026-11-12

This study is testing advanced MRI technology to see how it can help us understand the differences in brain images of people with early-stage Parkinson's disease compared to healthy individuals.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment200 (estimated)
SponsorChinese PLA General Hospital
Academic / other
Locations1 site (Beijing, Beijing, China)
StatusRecruiting
StartedMarch 1, 2022
Main results expectedJuly 1, 2027
Study endsJuly 1, 2030
Registry record updatedNovember 8, 2024
Trial IDNCT06449404 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients diagnosed with Parkinson's disease by a neurologist specializing in movement disorders.

Probably not a fit

Patients with other brain disorders, psychiatric disorders affecting cognitive function, or contraindications to MRI may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the imaging characteristics of patients with Parkinson's disease (PD) using 7-Tesla magnetic resonance imaging (MRI). The study will detect subtle changes in patients with early-stage PD compared to healthy individuals and investigate the different imaging characteristics among various subtypes of PD. Additionally, long-term follow-up will assess the correlation between imaging changes and clinical score alterations in PD patients.

Why it matters

Potential benefit: If successful, this study could lead to the identification of neuroimaging biomarkers that improve the diagnosis and management of Parkinson's disease.

How similar studies have gone: While studies using advanced MRI techniques in neurodegenerative diseases have shown promise, this specific approach with 7T MRI in Parkinson's disease is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* the patients with PD who was diagnosed by the experienced neurologist specializing in movement disorders

Exclusion Criteria:

* the patients with brain disorders such as cerebrovascular disease, brain tumors, epilepsy, other neurodegenerative disease;
* psychiatric disorders with impaired cognitive function;
* contraindications to MRI.

Where it's running

  • Chinese PLA General Hospital
    Beijing, Beijing, China, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.